Aluminum alters cyclic AMP and cyclic GMP levels but not presynaptic cholinergic markers in rat brain in vivo
- 1 February 1987
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 403 (1) , 1-6
- https://doi.org/10.1016/0006-8993(87)90115-6
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Age related decline in aluminum-activated human platelet adenylate cyclase: Post-receptor changes in cyclic AMP second messenger signal amplification in normal aging and dementia of the Alzheimer typeLife Sciences, 1986
- Neurochemical Abnormalities in Brains of Renal Failure Patients Treated by Repeated HemodialysisJournal of Neurochemistry, 1985
- INFANT FORMULA AS A CAUSE OF ALUMINIUM TOXICITY IN NEONATAL URAEMIAThe Lancet, 1985
- Neurotoxicity of aluminumCanadian Journal of Physiology and Pharmacology, 1984
- Do raised brain aluminium levels in Alzheimer's dementia contribute to cholinergic neuronal deficits?Medical Hypotheses, 1984
- Aluminum Intoxication from Aluminum-Containing Phosphate Binders in Children with Azotemia Not Undergoing DialysisNew England Journal of Medicine, 1984
- Aluminum IntoxicationNew England Journal of Medicine, 1984
- Aluminum interaction with calmodulinBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1983
- A simple and sensitive competitive protein-binding assay for cyclic GMPBiochemical and Biophysical Research Communications, 1975
- A rapid radiochemical method for the determination of choline acetyltransferaseJournal of Neurochemistry, 1975